Deutsche Bank AG Acquires New Shares in MetLife, Inc. $MET

Deutsche Bank AG bought a new stake in MetLife, Inc. (NYSE:METFree Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,602,601 shares of the financial services provider’s stock, valued at approximately $220,206,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Activest Wealth Management increased its stake in shares of MetLife by 205.8% in the 4th quarter. Activest Wealth Management now owns 315 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 212 shares during the last quarter. Garton & Associates Financial Advisors LLC acquired a new stake in shares of MetLife in the 4th quarter valued at approximately $30,000. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new position in MetLife during the 4th quarter worth approximately $31,000. Prosperity Bancshares Inc bought a new position in MetLife during the 4th quarter worth approximately $31,000. Finally, JPL Wealth Management LLC acquired a new position in MetLife during the third quarter valued at approximately $33,000. Institutional investors own 94.99% of the company’s stock.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

  • Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate
  • Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends
  • Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report
  • Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO

Analysts Set New Price Targets

Several brokerages have commented on MET. Jefferies Financial Group upped their target price on shares of MetLife from $97.00 to $103.00 and gave the company a “buy” rating in a research note on Friday, July 10th. Wall Street Zen lowered shares of MetLife from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Wells Fargo & Company upped their price objective on shares of MetLife from $95.00 to $101.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. Weiss Ratings raised MetLife from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, June 15th. Finally, Keefe, Bruyette & Woods lifted their target price on MetLife from $105.00 to $108.00 and gave the stock an “outperform” rating in a report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, MetLife currently has an average rating of “Moderate Buy” and an average target price of $101.07.

Read Our Latest Stock Analysis on MetLife

MetLife Stock Performance

Shares of MET stock opened at $96.83 on Wednesday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. MetLife, Inc. has a 52 week low of $67.33 and a 52 week high of $100.93. The company’s 50 day moving average price is $92.00 and its two-hundred day moving average price is $81.86. The company has a market capitalization of $62.31 billion, a P/E ratio of 18.55, a price-to-earnings-growth ratio of 0.75 and a beta of 0.78.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, beating the consensus estimate of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The company had revenue of $13.52 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter in the prior year, the company earned $2.02 earnings per share. The business’s quarterly revenue was up 10.5% compared to the same quarter last year. On average, analysts expect that MetLife, Inc. will post 9.7 earnings per share for the current fiscal year.

MetLife declared that its board has initiated a share buyback program on Wednesday, August 5th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the financial services provider to reacquire up to 4.8% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s management believes its shares are undervalued.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 8th. Investors of record on Tuesday, August 4th will be given a $0.5925 dividend. This represents a $2.37 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, August 4th. MetLife’s payout ratio is currently 45.40%.

About MetLife

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Further Reading

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.